학술논문
Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder
Document Type
Article
Author
Source
In: Journal of Affective Disorders . (Journal of Affective Disorders, 1 July 2022, 308:19-26)
Subject
Language
English
ISSN
15732517
01650327
01650327